Glofitamab Plus Polatuzumab Vedotin and Zuberitamab in Patients With Newly Diagnosed Diffuse Large B-cell Lymphoma
Sun Yat-sen University
Sun Yat-sen University
Institute of Hematology & Blood Diseases Hospital, China
Rush University Medical Center
Asan Medical Center
Ohio State University Comprehensive Cancer Center
Ontario Clinical Oncology Group (OCOG)
Northwestern University
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital